CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Report for D003110: Colonic Neoplasms NIH

(Synonyms: Colonic Neo, Colonic Neop, Colonic Neopl, Colonic Neoplas, Colonic Neoplasms)

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (5)


Name (Synonyms) Correlation
drug1245 Intracorporeal left hemicolectomy anastomosis Wiki 0.71
drug1833 Placebo Group Wiki 0.71
drug888 Experimental drug Wiki 0.71
drug901 Extracorporeal left hemicolectomy anastomosis Wiki 0.71
drug887 Experimental Group Wiki 0.71

Correlated MeSH Terms (0)


Name (Synonyms) Correlation

Correlated HPO Terms (1)


Name (Synonyms) Correlation
HP:0003003 Colon cancer HPO 1.00

There are 2 clinical trials

Clinical Trials


1 Patients' Preferences About Rescheduling Colonoscopies Delayed Due to COVID-19: Cross Sectional Study

The study is a cross-sectional survey study targeting patients aged 45-75 who had their screening or surveillance colonoscopy postponed or delayed due to the COVID pandemic. Study staff will survey a random subsample of patients to assess anxiety, COVID risk tolerance, cancer worry, willingness to screen and barriers to screening colonoscopy, and preference for colonoscopy and alternative colon cancer screening options. Eligible patients will be sent a survey packet in the mail that will include a cover letter, an information sheet describing the study, an incentive, and the survey. The cover letter will include information for participants to opt-out if they desire. Patients will be asked to complete the survey and return it back to study staff. Consent is implied with return of the survey. For the study, staff plan to invite 300 patients and expect to receive 195 completed surveys. Analyses will examine whether COVID-19 has changed patients' interest in colon cancer screening and the strength of patients' preferences for colonoscopy and other approaches to colon cancer screening. It will then examine factors associated with positive and negative views on rescheduling colonoscopies such as anxiety, worry, and risk perceptions.

NCT04432870 Colon Cancer
MeSH:Colonic Neoplasms
HPO:Colon cancer Neoplasm of the colon

Primary Outcomes

Description: Item with 5-point response assessing whether COVID-19 has increased, decreased or not changed interest in colon cancer screening

Measure: Interest in colon cancer screening

Time: at start of study--between one week and 2 months after start of study

Secondary Outcomes

Description: Item with 5-point response (definitely want to definitely do not want) measuring interest in having a stool test for colon cancer

Measure: Preference for stool testing

Time: at start of study--between one week and 2 months after start of study

Description: Item with 5-point response (definitely want to definitely do not want) measuring interest in postponing colonoscopy for one year

Measure: Preference for postponing colonoscopy for one year

Time: at start of study--between one week and 2 months after start of study

Description: Item with 5 point response (extremely worried to not at all worried) assessing worry about the delay of the colonoscopy on their colon cancer risk

Measure: Worry about delay

Time: at start of study--between one week and 2 months after start of study

Description: Item with 5-point response (very high to very low) assessing patients' perception about risk of getting COVID-19 from having a colonoscopy

Measure: Risk perception on COVID-19

Time: at start of study--between one week and 2 months after start of study

2 RESECTION AND INTRACORPOREAL ANASTOMOSIS IN LAPAROSCOPIC LEFT COLECTOMY AS AN ADAPTATION TO THE PANDEMIC CAUSED BY SARS-CoV-2 (COVID19). A COMPARATIVE COHORT STUDY

OBJECTIVE: The aim of the study is to demonstrate that the intracorporeal resection and anastomosis in left-sided colon cancer, sigma and upper rectum, is not inferior to extracoprporeal resection and anastomosis, in terms of anastomotic leakage. BACKGROUND: Due to the recent events of a pandemic respiratory disease secondary to infection by SARS-CoV-2 virus or coronavirus 19 (COVID19), surgeons have been forced to adapt our surgical procedures in order to minimize exposure to the virus as much as possible. Based on the recommendations in case of surgery in patients with highly contagious viral diseases, the latest studies suggest minimally invasive accesses to minimize the risk of contagion. One of the proposed measures is the performance of intracorporeal anastomoses. Therefore, given the extensive experience of our center in minimally invasive surgery and studies on the validation of intracorporeal anastomosis techniques in both laparoscopic surgery of the right colon and rectum (TaTME), and the study of advantages that they can provide to the patient, our intention is to apply it to surgery on the left colon, sigma and upper rectum. Our hypothesis is that exteriorization of the colon through an accessory incision increases the risk of tension at the mesocolon level, thus increasing the risk of vascular deficit at the level of the staple area and it may increase the rate of anastomotic leakage. In this sense, studies that validate a standard technique of intracorporeal anastomosis in left colon surgery and that demonstrate its benefit with respect to extracorporeal anastomosis are lacking. We intend to describe a new intracorporeal anastomosis technique (ICA) that is feasible and safe for the patient and that can be applied universally. Once the ICA technique is established, it will allow us to determine its non-inferiority compared to the standard technique performed up to now with extracorporeal anastomosis. METHODS: All consecutive patients with left-sided, sigma and upper rectum adenocarcinoma will be included into a prospective cohort and treated by laparoscopy with totally intracorporeal resection and anastomosis. They will be compared with a retrospective cohort of consecutive patients of identical characteristics treated by laparoscopy with extracorporeal resection and anastomosis, in the immediate chronological period.

NCT04456933 Colon Cancer Procedure: Extracorporeal left hemicolectomy anastomosis Procedure: Intracorporeal left hemicolectomy anastomosis
MeSH:Colonic Neoplasms
HPO:Colon cancer Neoplasm of the colon

Primary Outcomes

Description: Percentage of anastomic leak (defined in accordance with Peel et al.).

Measure: Percentage of anastomotic leak (AL)

Time: 30 days

Secondary Outcomes

Description: Dindo-Clavien Classification

Measure: Rate of global morbidity

Time: 30 days

Description: SSI in accordance with the Center for Disease Control (CDC) National

Measure: Rate of Surgical site infection

Time: 30 days

Description: Percentage of re-interventions due to surgical complications

Measure: Rate of Re-interventions

Time: 30 days


HPO Nodes